Bio-Rad’s Management to Host Investor Meetings at Citi's 2024 Global Healthcare Conference
21 11월 2024 - 11:00PM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global
leader in life science research and clinical diagnostics products,
today announced that the company's Chief Executive Officer Norman
Schwartz and Chief Financial Officer Roop K. Lakkaraju will host
one-on-one meetings with analysts and investors during Citi's 2024
Global Healthcare Conference in Miami, FL, December 3-5, 2024.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in
developing, manufacturing, and marketing a broad range of products
for the life science research and clinical diagnostics markets.
Based in Hercules, California, Bio-Rad operates a global network of
research, development, manufacturing, and sales operations with
approximately 7,700 employees, and $2.7 billion in revenues in
2023. Our customers include universities, research institutions,
hospitals, and biopharmaceutical companies, as well as clinical,
food safety and environmental quality laboratories. Together, we
develop innovative, high-quality products that advance science and
save lives. To learn more, visit bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241121721098/en/
Investor Contact: Edward Chung, Investor Relations
510-741-6104 ir@bio-rad.com
Media Contact: Anna Gralinska, Corporate Communications
510-741-6643 cc@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Bio Rad Laboratories (NYSE:BIO)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
